Literature DB >> 21924130

Challenges associated with application of clinical staging models to psychotic disorders.

Daniel H Mathalon1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21924130      PMCID： PMC4096294          DOI： 10.1016/j.biopsych.2011.08.007

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

Review 1.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?

Authors:  Daniel R Weinberger; Robert K McClure
Journal:  Arch Gen Psychiatry       Date:  2002-06

2.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry.

Authors:  Daniel H Mathalon; Judith L Rapoport; Kenneth L Davis; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2003-08

Review 3.  Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions.

Authors:  Patrick D McGorry; Ian B Hickie; Alison R Yung; Christos Pantelis; Henry J Jackson
Journal:  Aust N Z J Psychiatry       Date:  2006-08       Impact factor: 5.744

4.  Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry.

Authors:  Patrick D McGorry
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

Review 5.  Pharmacotherapy of first-episode schizophrenia.

Authors:  G Remington; S Kapur; R B Zipursky
Journal:  Br J Psychiatry Suppl       Date:  1998

6.  Antipsychotic medications and brain volume: do we have cause for concern?

Authors:  David A Lewis
Journal:  Arch Gen Psychiatry       Date:  2011-02

Review 7.  Neuroimaging and treatment evidence for clinical staging in psychotic disorders: from the at-risk mental state to chronic schizophrenia.

Authors:  Stephen J Wood; Alison R Yung; Patrick D McGorry; Christos Pantelis
Journal:  Biol Psychiatry       Date:  2011-07-18       Impact factor: 13.382

8.  Staging of disease. A case-mix measurement.

Authors:  J S Gonnella; M C Hornbrook; D Z Louis
Journal:  JAMA       Date:  1984-02-03       Impact factor: 56.272

9.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Steven Ziebell; Ronald Pierson; Vincent Magnotta
Journal:  Arch Gen Psychiatry       Date:  2011-02

10.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01
  10 in total
  4 in total

1.  Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification.

Authors:  Saeed Farooq; Ofer Agid; George Foussias; Gary Remington
Journal:  Schizophr Bull       Date:  2013-09-17       Impact factor: 9.306

2.  Improving outcomes of first-episode psychosis: an overview.

Authors:  Paolo Fusar-Poli; Patrick D McGorry; John M Kane
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

3.  Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300.

Authors:  Holly K Hamilton; Scott W Woods; Brian J Roach; Katiah Llerena; Thomas H McGlashan; Vinod H Srihari; Judith M Ford; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

4.  Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome.

Authors:  Holly K Hamilton; Brian J Roach; Peter M Bachman; Aysenil Belger; Ricardo E Carrion; Erica Duncan; Jason K Johannesen; Gregory A Light; Margaret A Niznikiewicz; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon; Daniel H Mathalon
Journal:  JAMA Psychiatry       Date:  2019-11-01       Impact factor: 21.596
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.